In re Warfarin Sodium Antitrust Litig., 391 F.3d at 536. The Court concludes that this factor counsels in favor of approving the Settlement. b. The Reaction of the Class to the Settlement The Court must next consider the reaction of the Class to the Settlement Agreement. Notice was sent to 2,572,342 current and former Health Net subscribers, and as noted above, Class Counsel has received 601 opt-outs in addition to the 1,107 timely opt outs received following certification and notice in McCoy and Wachtel. These 1,708 individuals represent approximately 0.066% of the total class. Class Counsel has received only nine objections. In a class of this size, this can only be considered an overwhelmingly favorable response. Cf. Stoetzner v. U.S. Steel Corp., 897 F.2d 115, 118-19 (3d Cir.1990) (<HOLDING>); see also In re Prudential, 148 F.3d at 318
holding that only 29 objections in 281 member class strongly favors settlement recognizing cause of action by class member against class counsel for negligence in providing notice recognizing that low number of objectors and optouts strongly favors settlement and that the vast disparity between the number of potential class members who received notice of the settlement and the number of objectors creates a strong presumption that this factor weighs in favor of the settlement holding that no class member may opt out of a rule 23b1 class action holding that there was no record of a hearing about settlement objections